Promise and perils for patients and physicians

New England Journal of Medicine

Volumn 353, Issue 26, 2005, Pages 2735-2739

  Kravitz, Richard L ^a   Chang, Sophia ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California HealthCare Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ORAL ANTIDIABETIC AGENT;

CLINICAL PHARMACY; CLINICAL PRACTICE; COUNSELING; DRUG COST; DRUG FORMULARY; DRUG UTILIZATION; GOVERNMENT; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MEDICARE; PATIENT CARE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

ALGORITHMS; CHOICE BEHAVIOR; COST SAVINGS; DEDUCTIBLES AND COINSURANCE; FORMULARIES; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MEDICAID; MEDICARE; PATIENTS; PHYSICIAN'S ROLE; PRESCRIPTION FEES; UNITED STATES;

EID: 29544435389     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp058248     Document Type: Short Survey

References (4)

1. Wolf R. Medicare prescription drug plan stumps seniors. USA Today. October 4, 2005:A3.
2. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med 2003;349:2224-32.
3. Alexander GC, Casalino LP, Meltzer DO. Physician strategies to reduce patients' outof-pocket prescription costs. Arch Intern Med 2005;165:633-6.
4. Shrank WH, Young HN, Ettner SL, Glassman P, Asch SM, Kravitz RL. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. Am J Manag Care 2005;11:16-22. [Erratum, Am J Manag Care 2005;11:180.]